Harmony Biosciences Holdings, Inc. (HRMY) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Harmony Biosciences Holdings, Inc. · Health Care · ref. ETF XLV · 66 calls · price $37.03
What the company does: Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States.
📈 Harmony Biosciences Holdings, Inc. (HRMY) stock price
$37.03+38.0% over range
Oct 14, 25low $25.9 · high $42.86Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
67% recommend buying · 6 analysts
📊 JPI status : Harmony Biosciences Holdings, Inc. is no longer in our current JPI rankings, but appeared in the past (2025) — its upside may be behind it. See the stocks picked in 2025 →
🎯 HRMY price target & analyst consensus — price $37.03
The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$60+62.0%
Median target · of 6 targets$50.5+36.4%
Lowest target · 1 firm of 6$34-8.2%
Current price$37.03
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
467%
$50 ↔ $60
Below
233%
$34 ↔ $36
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 60% of its targets hit on this sector (329 calls tested). It aims for $55 (+49 %), call made on October 14, 2026, maturing on October 14, 2027 (0 d ago).
The 1 reliable analyst
$55+49 %
The 5 other firms
$50+35 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $55 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy467%
Hold233%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 HRMY price target all
All 66 calls, one by one, with our verdict on each firm.
→ See all 66 targets, analyst by analyst💡 The best analysts on HRMY most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in HRMY? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Harmony Biosciences Holdings, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on HRMY
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Deutsche Bank ↗ | 67% | +17.3% | 3 |
| Raymond James ↗ | 67% | +4.0% | 6 |
| UBS ↗ | 50% | -3.0% | 2 |
| Cantor Fitzgerald ↗ | 50% | -7.4% | 8 |
| Needham ↗ | 45% | -4.2% | 38 |
| HC Wainwright & Co. ↗ | 43% | +4.2% | 7 |
| Mizuho ↗ | 41% | -10.1% | 17 |
| Piper Sandler ↗ | 33% | -0.1% | 3 |
| Goldman Sachs ↗ | 25% | +10.8% | 4 |
| Oppenheimer ↗ | 17% | -4.7% | 6 |
📊 What $1,000 invested in Harmony Biosciences Holdings, Inc. would be worth › open the full page
In short — $1,000 invested in Harmony Biosciences Holdings, Inc. 10 years ago would be worth $967 today, i.e. -1%/yr on average. Best year: 2022 (+29%), worst: 2023 (-41%). Price performance, excluding dividends.
If I'd invested $1,000 in Harmony Biosciences Holdings, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,001 | +0% |
| 3 years ago | $632 | -37% |
| 5 years ago | $963 | -4% |
Return by year (Harmony Biosciences Holdings, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -7% | $931 (-7%) |
| 2025 | +7% | $1,001 (+0%) |
| 2024 | +8% | $1,078 (+8%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Harmony Biosciences Holdings, Inc.
Loading news…
📋 All analyst calls on HRMY
Filtered on — · ✕ show all
HC Wainwright & Co. ↗
Oct 13, 26
▲ Buy · 🎯$55
Price at call : $37.03 — upside +49%
Today : $37.03 — upside +49%
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
▲ Buy · 🎯$50
Price at call : $38.23 — upside +31%
Today : $37.03 — upside +35%
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
Wolfe Research ↗
Aug 26, 26
▲ Outperform · 🎯$60
Price at call : $39.66 — upside +51%
Today : $37.03 — upside +62%
🎯 on HRMY : no call matured yet · 📊 overall : 34.9% · -2.8% (109 calls)
in progress (365j)
matures : Aug 26, 27
matures : Aug 26, 27
Truist Securities ↗
Aug 5, 26
■ Hold neutral · not a buy · 🎯$34
Price at call : $38.75 — gap to target -12%
Today : $37.03 — gap to target -8%
🎯 on HRMY : 100% (1 call matured) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Buy · 🎯$50
Price at call : $38.24 — upside +31%
Today : $37.03 — upside +35%
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Outperform · 🎯$51
Price at call : $35.6 — upside +43%
Today : $37.03 — upside +38%
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
HC Wainwright & Co. ↗
Jul 16, 26
▲ Buy · 🎯$55
Price at call : $33.77 — upside +63%
Today : $37.03 — upside +49%
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
Deutsche Bank ↗
Jun 30, 26
■ Hold neutral · not a buy · 🎯$36
Price at call : $36 — gap to target +0%
Today : $37.03 — gap to target -3%
🎯 on HRMY : 67% (3 calls matureds) · 📊 on Health : 33.9% · -7.0% (56 calls)
in progress (365j)
matures : Jun 30, 27
matures : Jun 30, 27
See the other 58 calls, newest to oldest
Truist Securities ↗
May 8, 26
■ Hold neutral · not a buy · 🎯$29
Price at call : $30.18 — gap to target -4%
Today : $37.03 — gap to target -22%
🎯 on HRMY : 100% (1 call matured) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
■ Neutral neutral · not a buy · 🎯$36
Price at call : $29.05 — gap to target +24%
Today : $37.03 — gap to target -3%
🎯 on HRMY : 100% (1 call matured) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
HC Wainwright & Co. ↗
Feb 25, 26
▲ Buy · 🎯$55
Price at call : $29.05 — upside +89%
Today : $37.03 — upside +49%
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
B of A Securities ↗
Feb 25, 26
▼ Underperform · 🎯$28
Price at call : $28.19 — upside -1%
Today : $37.03 — upside -24%
🎯 on HRMY : no call matured yet · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Buy · 🎯$44
Price at call : $28.19 — upside +56%
Today : $37.03 — upside +19%
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
■ Neutral neutral · not a buy · 🎯$46
Price at call : $36.59 — gap to target +26%
Today : $37.03 — gap to target +24%
🎯 on HRMY : 100% (1 call matured) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
Truist Securities ↗
Jan 8, 26
▲ Buy · 🎯$45
Price at call : $38.55 — upside +17%
Today : $37.03 — upside +22%
🎯 on HRMY : 100% (1 call matured) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
▲ Outperform · 🎯$46
Price at call : $35.51 — upside +30%
Today : $37.03 — upside +24%
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Dec 1, 26
matures : Dec 1, 26
HC Wainwright & Co. ↗
Nov 24, 25
▲ Buy · 🎯$55
Price at call : $35.34 — upside +56%
Today : $37.03 — upside +49%
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Nov 24, 26
matures : Nov 24, 26
▲ Buy · 🎯$42
Price at call : $35.34 — upside +19%
Today : $37.03 — upside +13%
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Nov 24, 26
matures : Nov 24, 26
▲ Outperform · 🎯$39
Price at call : $31.43 — upside +24%
Today : $37.03 — upside +5%
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$43
Price at call : $25.95 — upside +66%
Today : $37.03 — upside +16%
🎯 on HRMY : 100% (1 call matured) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
▲ Outperform · 🎯$35
Price at call : $27.51 — upside +27%
Today : $37.03 — upside -5%
Expected +27% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+45.4%
stock +45% · XLV +26%
matured Sep 25, 26
Deutsche Bank ↗
Sep 25, 25
▲ Buy · 🎯$36
Price at call : $27.04 — upside +33%
Today : $37.03 — upside -3%
Expected +33% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on HRMY : 67% (3 calls matureds) · 📊 on Health : 33.9% · -7.0% (56 calls)
+52.6%
stock +53% · XLV +27%
matured Sep 25, 26
HC Wainwright & Co. ↗
Sep 25, 25
▲ Buy · 🎯$55
Price at call : $27.04 — upside +103%
Today : $37.03 — upside +49%
Expected +103% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+52.6%
stock +53% · XLV +27%
matured Sep 25, 26
▲ Buy · 🎯$41
Price at call : $27.04 — upside +52%
Today : $37.03 — upside +11%
Expected +52% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+52.6%
stock +53% · XLV +27%
matured Sep 24, 26
Truist Securities ↗
Jul 21, 25
▲ Buy · 🎯$48
Price at call : $35.25 — upside +36%
Today : $37.03 — upside +30%
Expected +36% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 100% (1 call matured) · 📊 on Health : 38.1% · -0.3% (168 calls)
+4.5%
stock +5% · XLV +22%
matured Jul 21, 26
Deutsche Bank ↗
Jul 10, 25
▲ Buy · 🎯$55
Price at call : $34 — upside +62%
Today : $37.03 — upside +49%
Expected +62% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 67% (3 calls matureds) · 📊 on Health : 33.9% · -7.0% (56 calls)
+4.5%
stock +5% · XLV +19%
matured Jul 10, 26
▲ Outperform · 🎯$48
Price at call : $35.07 — upside +37%
Today : $37.03 — upside +30%
Expected +37% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-14.9%
stock -15% · XLV +9%
matured May 15, 26
▲ Buy · 🎯$49
Price at call : $33.44 — upside +47%
Today : $37.03 — upside +32%
Expected +47% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-6.0%
stock -6% · XLV +7%
matured May 7, 26
▲ Buy · 🎯$49
Price at call : $32.05 — upside +53%
Today : $37.03 — upside +32%
Expected +53% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+2.3%
stock +2% · XLV +8%
matured May 6, 26
▲ Buy · 🎯$48
Price at call : $29.44 — upside +63%
Today : $37.03 — upside +30%
Expected +63% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 100% (1 call matured) · 📊 on Health : 48.7% · +2.2% (76 calls)
+5.5%
stock +5% · XLV +3%
matured Apr 28, 26
▲ Buy · 🎯$50
Price at call : $28.99 — upside +72%
Today : $37.03 — upside +35%
Expected +72% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-0.3%
stock -0% · XLV +9%
matured Apr 10, 26
HC Wainwright & Co. ↗
Apr 8, 25
▲ Buy · 🎯$70
Price at call : $29.07 — upside +141%
Today : $37.03 — upside +89%
Expected +141% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+0.3%
stock +0% · XLV +8%
matured Apr 8, 26
▲ Buy · 🎯$50
Price at call : $29.07 — upside +72%
Today : $37.03 — upside +35%
Expected +72% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+0.3%
stock +0% · XLV +8%
matured Apr 8, 26
▲ Outperform · 🎯$44
Price at call : $34.78 — upside +27%
Today : $37.03 — upside +19%
Expected +27% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-19.9%
stock -20% · XLV +0%
matured Mar 18, 26
HC Wainwright & Co. ↗
Feb 27, 25
▲ Buy · 🎯$70
Price at call : $32.75 — upside +114%
Today : $37.03 — upside +89%
Expected +114% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-12.8%
stock -13% · XLV +9%
matured Feb 27, 26
▲ Buy · 🎯$50
Price at call : $33.47 — upside +49%
Today : $37.03 — upside +35%
Expected +49% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-13.2%
stock -13% · XLV +6%
matured Feb 26, 26
▲ Buy · 🎯$50
Price at call : $36.97 — upside +35%
Today : $37.03 — upside +35%
Expected +35% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-23.8%
stock -24% · XLV +6%
matured Feb 25, 26
▲ Outperform · 🎯$42
Price at call : $34.56 — upside +22%
Today : $37.03 — upside +13%
Expected +22% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-22.3%
stock -22% · XLV +8%
matured Feb 20, 26
HC Wainwright & Co. ↗
Feb 19, 25
▲ Buy · 🎯$75
Price at call : $34.89 — upside +115%
Today : $37.03 — upside +103%
Expected +115% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-16.4%
stock -16% · XLV +7%
matured Feb 19, 26
▲ Buy · 🎯$50
Price at call : $34.89 — upside +43%
Today : $37.03 — upside +35%
Expected +43% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-16.4%
stock -16% · XLV +7%
matured Feb 19, 26
Deutsche Bank ↗
Feb 11, 25
▲ Buy · 🎯$55
Price at call : $37.84 — upside +45%
Today : $37.03 — upside +49%
Expected +45% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 67% (3 calls matureds) · 📊 on Health : 33.9% · -7.0% (56 calls)
-5.3%
stock -5% · XLV +7%
matured Feb 11, 26
HC Wainwright & Co. ↗
Jan 27, 25
▲ Buy · 🎯$75
Price at call : $38.25 — upside +96%
Today : $37.03 — upside +103%
Expected +96% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-1.5%
stock -1% · XLV +5%
matured Jan 27, 26
HC Wainwright & Co. ↗
Jan 16, 25
▲ Buy · 🎯$75
Price at call : $39.05 — upside +92%
Today : $37.03 — upside +103%
Expected +92% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-8.0%
stock -8% · XLV +11%
matured Jan 16, 26
▲ Buy · 🎯$52
Price at call : $36.42 — upside +43%
Today : $37.03 — upside +40%
Expected +43% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-1.0%
stock -1% · XLV +13%
matured Jan 13, 26
Oppenheimer ↗
Jan 13, 25
▲ Outperform · 🎯$61
Price at call : $36.45 — upside +67%
Today : $37.03 — upside +65%
Expected +67% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 0% (2 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-1.9%
stock -2% · XLV +11%
matured Jan 13, 26
HC Wainwright & Co. ↗
Dec 17, 24
▲ Buy · 🎯$75
Price at call : $33.63 — upside +123%
Today : $37.03 — upside +103%
Expected +123% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on HRMY : 43% (7 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+15.3%
stock +15% · XLV +10%
matured Dec 17, 25
Cantor Fitzgerald ↗
Oct 30, 24
▲ Overweight · 🎯$58
Price at call : $32.13 — upside +81%
Today : $37.03 — upside +57%
Expected +81% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (8 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
-11.1%
stock -11% · XLV -2%
matured Oct 30, 25
Oppenheimer ↗
Oct 30, 24
▲ Outperform · 🎯$59
Price at call : $32.13 — upside +84%
Today : $37.03 — upside +59%
Expected +84% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 0% (2 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-11.1%
stock -11% · XLV -2%
matured Oct 30, 25
▲ Buy · 🎯$52
Price at call : $33.8 — upside +54%
Today : $37.03 — upside +40%
Expected +54% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-14.5%
stock -14% · XLV -3%
matured Oct 30, 25
▲ Buy · 🎯$52
Price at call : $41.49 — upside +25%
Today : $37.03 — upside +40%
Expected +25% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-29.3%
stock -29% · XLV -3%
matured Oct 29, 25
▲ Outperform · 🎯$52
Price at call : $34.81 — upside +49%
Today : $37.03 — upside +40%
Expected +49% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-23.8%
stock -24% · XLV -7%
matured Oct 10, 25
▲ Buy · 🎯$52
Price at call : $35.57 — upside +46%
Today : $37.03 — upside +40%
Expected +46% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 25% (12 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-24.8%
stock -25% · XLV -6%
matured Oct 2, 25
Cantor Fitzgerald ↗
Apr 12, 24
▲ Overweight · 🎯$49
Price at call : $29.52 — upside +66%
Today : $37.03 — upside +32%
Expected +66% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (8 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+0.0%
stock +0% · XLV -0%
matured Apr 12, 25
Cantor Fitzgerald ↗
Mar 28, 24
▲ Overweight · 🎯$49
Price at call : $33.01 — upside +48%
Today : $37.03 — upside +32%
Expected +48% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (8 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+0.5%
stock +1% · XLV -0%
matured Mar 28, 25
▲ Buy · 🎯$40
Price at call : $33.26 — upside +20%
Today : $37.03 — upside +8%
Expected +20% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-1.5%
stock -2% · XLV +1%
matured Feb 26, 25
Cantor Fitzgerald ↗
Feb 23, 24
▲ Overweight · 🎯$49
Price at call : $32.47 — upside +51%
Today : $37.03 — upside +32%
Expected +51% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (8 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+5.3%
stock +5% · XLV +0%
matured Feb 22, 25
▲ Buy · 🎯$42
Price at call : $33.02 — upside +27%
Today : $37.03 — upside +13%
Expected +27% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+18.4%
stock +18% · XLV -0%
matured Feb 16, 25
▲ Buy · 🎯$54
Price at call : $32.24 — upside +67%
Today : $37.03 — upside +46%
Expected +67% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+7.3%
stock +7% · XLV +18%
matured Oct 3, 24
▲ Buy · 🎯$54
Price at call : $37.35 — upside +45%
Today : $37.03 — upside +46%
Expected +45% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+4.4%
stock +4% · XLV +19%
matured Sep 18, 24
▲ Buy · 🎯$54
Price at call : $35.34 — upside +53%
Today : $37.03 — upside +46%
Expected +53% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+1.2%
stock +1% · XLV +16%
matured Aug 28, 24
Cantor Fitzgerald ↗
Aug 22, 23
▲ Overweight · 🎯$75
Price at call : $32.01 — upside +134%
Today : $37.03 — upside +103%
Expected +134% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (8 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+12.5%
stock +13% · XLV +16%
matured Aug 21, 24
▲ Buy · 🎯$54
Price at call : $32.56 — upside +66%
Today : $37.03 — upside +46%
Expected +66% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-0.5%
stock -0% · XLV +14%
matured Aug 2, 24
Cantor Fitzgerald ↗
Jun 23, 23
▲ Overweight · 🎯$75
Price at call : $35.66 — upside +110%
Today : $37.03 — upside +103%
Expected +110% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (8 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
-15.6%
stock -16% · XLV +12%
matured Jun 22, 24
Cantor Fitzgerald ↗
May 3, 23
▲ Overweight · 🎯$75
Price at call : $35.99 — upside +108%
Today : $37.03 — upside +103%
Expected +108% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (8 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
-11.9%
stock -12% · XLV +5%
matured May 2, 24
▲ Buy · 🎯$60
Price at call : $32.68 — upside +84%
Today : $37.03 — upside +62%
Expected +84% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (12 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+1.0%
stock +1% · XLV +14%
matured Mar 29, 24
Cantor Fitzgerald ↗
Apr 14, 22
▲ Overweight · 🎯$63
Price at call : $51.54 — upside +22%
Today : $37.03 — upside +70%
Expected +22% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on HRMY : 50% (8 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
-38.9%
stock -39% · XLV -3%
matured Apr 14, 23
Frequently asked questions
Should I buy Harmony Biosciences Holdings, Inc. stock?
This isn't buy advice. For Harmony Biosciences Holdings, Inc., the analyst consensus is "Buy", with an average price target of $50.50 (+36% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 67% of the time (3 calls tracked on Harmony Biosciences Holdings, Inc.). We show the numbers — you decide.
Is it too late to buy Harmony Biosciences Holdings, Inc.? How high can it go?
The most bullish analyst target on Harmony Biosciences Holdings, Inc. is $60.00 (+62% above today's price); the average is $50.50. That's the upside they see. Check how reliable those analysts have actually been on Harmony Biosciences Holdings, Inc. on our site before trusting it.
Is Harmony Biosciences Holdings, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Harmony Biosciences Holdings, Inc., the best hitting 67% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Harmony Biosciences Holdings, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in HRMY (and why hesitate).
What has Harmony Biosciences Holdings, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: HRMY performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX